Target intelligence / Profile preview

Rotavirus A VP7 (G6) and VP4 (P) antigens (RV G6P)

Target
RV G6P
Molecular classification
Viral surface protein, Glycoprotein, Antigen
01

Overview

Rotavirus G6P antigens are the primary surface proteins of specific Rotavirus A strains, specifically the VP7 (glycoprotein, G-type) and VP4 (protease-sensitive, P-type) proteins. These proteins form the outer capsid of the virus and are responsible for mediating viral attachment and entry into host enterocytes in the small intestine [Source: UniProt, P12473 (VP7), P12472 (VP4)]. The G6 serotype is frequently associated with bovine rotavirus strains, such as the WC3 strain, which serves as the genetic backbone for the pentavalent RotaTeq vaccine [Source: PubMed, PMID: 18467240]. In the context of vaccination, these antigens are used to induce a robust immune response, characterized by the production of neutralizing antibodies that block viral infection [Source: FDA, RotaTeq Package Insert]. Because rotavirus is a leading cause of severe dehydrating diarrhea in infants and young children worldwide, these antigens are critical targets for preventative medicine. Monitoring the prevalence of G6 and other serotypes is vital for assessing vaccine coverage and the potential for zoonotic transmission or reassortment.

Other names
Rotavirus outer capsid proteinsVP7 G6 serotypeVP4 P-type proteinBovine rotavirus G6P antigenOuter capsid protein VP7/VP4
02

Mechanism of action

Active immunization through the induction of neutralizing antibodies against the VP7 and VP4 outer capsid proteins

03

Biological functions

Viral attachmentCell entryImmune response inductionNeutralization antigen
04

Disease associations

GastroenteritisInfectionDiarrheal disease
05

Safety considerations

IntussusceptionVaccine-derived reassortmentViral shedding in stool
06

Interacting drugs

RotaTeq (Pentavalent Rotavirus Vaccine, Live, Oral)

1 more in the full profile.

07

Biomarkers

Anti-rotavirus IgANeutralizing antibody titers (SNA)Fecal rotavirus antigen

Beyond the preview

Go deeper on Rotavirus A VP7 (G6) and VP4 (P) antigens (RV G6P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus A VP7 (G6) and VP4 (P) antigens (RV G6P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call